Related Experiment Video
Updated: Jan 17, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Non-inflammatory mimickers of myositis: a guide for rheumatologists
Susana P Silva1, Miguel Pinto2, Diogo Costa3
1Rheumatology Department, Unidade Local de Saúde da Região de Aveiro; and Aveiro Rheumatology Research Centre, Centro Académico Clínico Egas Moniz Health Alliance, Aveiro, Portugal. 72868@ulsra.min-saude.pt.
None:
Muscle dysfunction presenting with weakness and elevated muscle enzymes poses a significant diagnostic challenge for rheumatologists, particularly in differentiating idiopathic inflammatory myopathies (IIM) from other mimicking conditions. This review systematically categorises non-inflammatory muscle diseases, including drug-induced myopathies, endocrine myopathies, genetic muscular dystrophies, metabolic and mitochondrial myopathies, and neuromuscular junction disorders, that can clinically and histologically resemble myositis. We emphasise the importance of a detailed clinical evaluation, including history, pattern of muscle involvement, extramuscular features, and comprehensive laboratory and biopsy investigations, to avoid misdiagnosis. Awareness of these mimickers is crucial for guiding appropriate diagnostic workup and management, given the distinct therapeutic approaches required for each condition. This framework aims to assist rheumatologists in improving diagnostic accuracy, optimising patient management, and enhancing referral decisions in patients presenting with muscle weakness.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

